Eli Lilly's online health platform just expanded beyond weight loss to tackle Alzheimer's
'We know that early diagnosis and care can make a big difference for people living with Alzheimer's disease,' said David Hyman, Eli Lilly's chief medical officer, in a press release. 'By expanding this platform, we hope to help patients identify and access additional independent specialty care capacity, which can coordinate with a patient's existing care team.'
The company says the goal is to reduce the long wait times many patients face in getting an appointment with specialists.
Alzheimer's is a progressive brain disorder caused by nerve cell damage, leading to memory loss, difficulty with daily activities, and, eventually, the inability to communicate or respond to the environment. An estimated 6.9 million Americans 65 and older were living with the disease in 2024, according to the Alzheimer's Association.
Unlike other conditions covered by LillyDirect, the Alzheimer's resources won't include mail-order pharmacy services for Lilly's medications. Instead, the platform will focus on education and helping patients connect with independent healthcare providers.
The platform will offer connections to both in-person and telehealth specialists via Healthgrades, an independent doctor locator tool, and Synapticure, a telehealth provider specializing in neurodegenerative care.
The news also comes after the U.S. Food and Drug Administration (FDA) approved Eli Lilly's once-monthly Alzheimer's treatment, Kisunla, last summer. In a late-stage clinical trial, patients with mild symptoms saw the most benefit, with a 35% slower decline in memory, thinking, and daily activities compared to patients on a placebo.
For the latest news, Facebook, Twitter and Instagram.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
an hour ago
- USA Today
With a new COVID variant on the rise, which US states have the most cases?
Some states are being hit harder than others this summer as a new COVID-19 strain (XGF) continues to spread. Some regions of the U.S. are still experiencing higher rates of positive COVID tests than others, though reporting has slowed down enough nationwide that the Centers for Disease Control (CDC) has begun allowing more time to pass between certain types of updates, such as those on variant prevalence. Testing, cases, hospitalizations and deaths are still being recorded on a weekly basis, however, even amid the chaos of ever-changing strains, recommendations and cuts to vaccine development funding. Here's what to know about the latest data. How many COVID cases were reported nationwide? During the week ending on Aug. 2, 8.5% of the 25,731 Americans tested were positive for COVID, according to the CDC's latest data. This was 2% increase from the week prior. During the same period, only 0.3% of cases resulted in death and 0.9% resulted in an emergency room visit, a 0.1% decrease from the week prior for both categories. More: What is an mRNA vaccine, and why is it controversial? Where are the most COVID cases being reported? See map Western and southern states, including Washington, Oregon, Idaho, California, Nevada, Arizona, New Mexico, Texas, Oklahoma, Arkansas and Louisiana, had higher percentages of positive COVID tests during the week ending Aug. 2. What is the most common COVID variant? The CDC has moved to using longer data timeframes for COVID tracking due to low reporting from states. According to the latest data for the two weeks ending June 21, variant NB.1.8.1 remained the most common, accounting for 43% of cases, followed by LP.8.1 at 31% of cases and XFG at 14%. NB.1.8.1 experienced a meteoric rise to becoming the predominant variant, accounting for 0% of cases in April and only 10% in the last week of May, up to 24% at the beginning of June and 43% by the end. XFG, a combination of variants F.7 and LP.8.1.2, is on the rise as of late, having been responsible for 0% of U.S. cases through March, 11% by early June and 14% by late June.
Newsweek
5 hours ago
- Newsweek
Chocolate Recall Sparks Nationwide Warning to Customers
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Neuhaus Chocolates NV is recalling their Belgian Chocolate Moments Smurfs 'Popping Milk Chocolates with Cookies because the product contains wheat which was not declared on the packaging. Newsweek reached out to the company via email Monday for comment. Why It Matters Numerous recalls have been initiated this year due to the potential for damaged products, foodborne illness, contamination and undeclared food allergens. Millions of Americans experience food sensitivities or allergies every year. According to the U.S. Food and Drug Administration (FDA), the nine "major" food allergens in the U.S. are eggs, milk, fish, wheat, soybeans, Crustacean shellfish, sesame, tree nuts and peanuts. People with a wheat allergy could experience a "serious or life-threatening allergic reaction if they consume these products," the FDA warns. What To Know Neuhaus Chocolate can be seen related to a recall in August 2025. (Photo from the U.S. Food and Drug Administration) Neuhaus Chocolate can be seen related to a recall in August 2025. (Photo from the U.S. Food and Drug Administration) In the alert, the FDA says the recalled chocolates were distributed from July 21, 2025, until August 4, 2025, by Neuhaus stores in Virginia, New York, Pennsylvania, Maryland, Washington, D.C. and via their online store. The impacted batch numbers are 80108690 and 80108763 with a best use before date of January 13, 2026, the FDA alert says. There have been no reports of illnesses related to this recall and 150 units of the impacted products were sold, the FDA says. What People Are Saying The FDA in their alert in part: "The action was initiated after it was discovered during an internal check that product containing wheat was distributed in packaging that did not reveal the presence of wheat. Subsequent investigation indicates the problem was caused by an exceptional combination of circumstances in which the ERP (Enterprise Resource Planning) did not include the allergen on the packaging." In an email to Newsweek in January, the FDA said: "Most recalls in the U.S. are carried out voluntarily by the product manufacturer and when a company issues a public warning, typically via news release, to inform the public of a voluntary product recall; the FDA shares that release on our website as a public service. "The FDA's role during a voluntary, firm-initiated, recall is to review the recall strategy, evaluate the health hazard presented by the product, monitor the recall, and as appropriate alert the public and other companies in the supply chain about the recall. "The FDA provides public access to information on recalls by posting a listing of recalls according to their classification in the FDA Enforcement Report, including the specific action taken by the recalling company. The FDA Enforcement Report is designed to provide a public listing of products in the marketplace that are being recalled." Additional information on recalls can be found via the FDA's Recalls, Market Withdrawals, & Safety Alerts. What Happens Next Customers who have purchased the recalled product who have a wheat allergy are asked to return it to the original place of purchase and not to consume it, the FDA says. People with additional questions may contact the company via phone at +32 2 568 23 00 from 8 a.m. to 5 p.m. Central European Summer Time on weekdays or via email at customercare@
USA Today
6 hours ago
- USA Today
Millions will lose Medicaid under Trump's tax law. Here's the final tally.
About 10 million Americans are expected to lose health insurance under President Donald Trump's tax cut and spending law, the nonpartisan Congressional Budget Office said. Over the next decade, 7.5 million people will lose Medicaid coverage due to changes under the law, the CBO said in an analysis released Monday, Aug. 11. Nondisabled adults on Medicaid will be required to get a job, volunteer or enroll in school to maintain their Medicaid coverage. And states must double Medicaid eligibility checks to twice a year. Another 2.1 million people will shed Affordable Care Act coverage over the next decade, the CBO said. And 400,000 more will lose coverage due to impacts of the law — nicknamed the One Big Beautiful Bill — which was backed by Congressional Republicans. The CBO earlier said the legislation, which Trump signed on July 4, would add $3.4 trillion to the federal deficit. The law extends the 2017 tax cuts, ends taxes on tips and overtime, and bolsters border security, among other things. The CBO also estimated low-income Americans will lose about $1,200 per year due to Medicaid changes and reductions in food assistance. Middle-income households are expected to gain $800 to $1,200. Meanwhile, the law's tax cuts will benefit wealthier Americans by about $13,600 per year, even though these households with pay about $190,000 in federal taxes annually, the CBO said. Millions more could lose their health insurance When the bill passed the Senate, the CBO estimated it would leave about 11.8 million Americans without health insurance through 2034. The law signed by Trump won't cut as deep because it excluded a provision that would've penalized states extending Medicaid to undocumented residents. Still, another 5 million could lose coverage if Congress doesn't extend the expiring COVID-19 pandemic-era tax credits that have made Affordable Care Act plans more affordable for consumers, according to earlier CBO estimates. Consumers who use those pandemic-era tax credits will see the amount they need to pay spike an average of more than 75%, according to KFF, a health policy nonprofit. The combination of the tax law, expiring tax credits and overall rising medical costs will make insurance premiums more expensive for everyone. Insurers plan a median premium increase of 18% for 2026 plans, which would be the largest ACA insurance price hike since 2018, according to a Peterson-KFF Health System Tracker report released Aug. 6.
